Identification of Novel Modalities Through Bibliometric Analysis for Timely Development of Regulatory Guidance: A Case Study of T Cell Immunity

Background: The mission of medicines regulatory agencies is to ensure the timely access of innovative products for patients to improve public health. Thus, regulators should foresee evolving technologies and build expertise prior to reviewing innovative products. Novel modalities and new classes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukaya-Shiba, Ai, Otsuka, Kouhei, Sasaki, Hajime, Shikano, Mayumi, Wakao, Rika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544749/
https://www.ncbi.nlm.nih.gov/pubmed/34708061
http://dx.doi.org/10.3389/fmed.2021.756870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544749/
https://www.ncbi.nlm.nih.gov/pubmed/34708061
http://dx.doi.org/10.3389/fmed.2021.756870

Ejemplares similares